Longevity medicine mainstreaming: tesamorelin fits squarely into the longevity conversation, where visceral fat reduction and cognitive preservation are both high-priority outcomes
This indication diversification insulates GLP-1 manufacturers from reimbursement pressure in any single category while creating cross-indication pricing power
Notably, these effects occurred at relatively low doses, were well-tolerated, and were accompanied by weight loss
Among the 4,076 participants, 80% were receiving ACE inhibitors, ARBs, or angiotensin receptor-neprilysin inhibitors, and 15.2% were on SGLT2 inhibitors
Cost at Elevated Health And How to Pay With Pre-Tax Dollars Medication Pricing No Insurance Required And Both Are HSA-Eligible Elevated Health does not accept health insurance
This happens with all kinds of weight loss, not just weight loss on GLP-1 drugs